CytImmune Sciences' Debt Round

CytImmune Sciences raised a round of funding on January 22, 2010.

CytImmune Sciences is a clinical stage nanomedicine company with a core focus on the discovery, development and commercialization of multifunctional, tumor-targeted therapies. Based on an R&D strategy…

Articles about CytImmune Sciences' Debt Round: